Nature Biotechnology 2006 Stacy Lawrence - Abstracts
| Nature Biotechnology 2006 Stacy Lawrence | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Amgen's TPO mimic faces stiff competition.(Amgen Biologicals/Diagnostics) | Business | Stacy Lawrence | |||
| Looking for the ripple effect.(California. Stem Cell Research and Cures Act of 2004) | Business | Stacy Lawrence | |||
| Public biotechnology 2005- the numbers. | Business | Riku Lahteenmaki, Stacy Lawrence | |||
| Reverse mergers attract top-tier biotechs in sluggish IPO market. | Business | Stacy Lawrence | |||
| Sarbanes-Oxley rules to be relaxed? | Business | Stacy Lawrence | |||
| Shift toward early-stage deals favors bioteochs. | Business | Stacy Lawrence | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.